Beyond stop-loss: Smarter claim strategies for a high-cost era

Catastrophic medical claims are no longer outliers. They’ve become a routine challenge for brokers and their self-insured employer clients. Whether it’s a million-dollar cancer treatment, an organ transplant or a high-cost specialty drug regimen, the financial impact of a single claim can destabilize an entire plan year and drive up stop-loss premiums for years to come.

Stop-loss insurance remains a critical line of defense. In today’s claim environment, it’s not enough to simply cap losses. Brokers must help their clients combine stop-loss coverage with strategic claim review, negotiation and pricing tactics that reduce spend before a claim hits the deductible and long before it triggers catastrophic thresholds.

The shifting ground beneath stop-loss

The stop-loss market has grown rapidly in response to the volatility of large claims. More employers, especially in the midsize group segment, are turning to stop-loss as a financial buffer against unpredictable and severe medical events. However, two key dynamics are altering how that protection performs.

First, the frequency of multimillion-dollar claims has increased dramatically. Sun Life reported that million-dollar claims rose by 8% on a claims-per-million-covered-employees basis between 2023 and 2024, with those claims up by 50% over the period 2020-2024. Medical inflation, the introduction of costly advanced therapies, hospital and health system consolidation and the elimination of lifetime benefit limits have made large claims more common than ever before. What was once an outlier has become routine.

Second, as stop-loss carriers experience rising loss ratios, they are responding with more restrictive underwriting. Premiums are increasing, contract terms are tightening, and carriers are applying more scrutiny to how employers manage and document their claims. 

This shift exposes plan sponsors who lack proactive cost-containment strategies. Without a process to reduce or contest inflated claims early on, employers are left vulnerable to overpaying, regardless of whether those claims ultimately breach the stop-loss threshold.

When protection becomes a false sense of security

Stop-loss insurance is designed to protect a plan from catastrophic losses. While it caps exposure at the top, many plans overlook what’s happening at the bottom, where the bulk of unnecessary costs accumulate. This is where financial leakage often occurs.

Several recurring problem areas contribute to inflated claims. Out-of-network charges are often submitted at rates far above what the market considers reasonable. In-network facility claims, although seemingly protected by contracted pricing, may be governed by vague or loosely enforced terms, leading to inconsistent reimbursement. 

Billing errors — such as duplicate charges, unbundled procedures or misapplied coding — frequently go undetected. High-cost services such as dialysis and infusion therapy are often billed on a recurring basis without proper pricing controls in place. In some cases, treatments that are experimental or not medically necessary are approved and reimbursed as standard care.

Without intervention, these issues not only drive up costs but can also jeopardize reimbursement from the stop-loss carrier. If a large claim is poorly documented or lacks justification, it may be contested or denied during stop-loss review. That’s why a more disciplined approach to managing claim-level detail is essential, even before stop-loss comes into play.

Three strategic levers to strengthen financial protection

To reduce risk exposure and build a stronger financial foundation, brokers should guide their clients toward combining stop-loss coverage with a more active approach to claims management. Three strategies in particular can make a significant impact: negotiation, review and independent clinical validation.

1. Claim negotiation

Claim negotiation is no longer reserved for occasional out-of-network surprises. It has become a critical tool for managing the cost of both high-dollar in-
network and out-of-network claims across all care settings.

What differentiates effective negotiation today is expertise. Highly experienced negotiators who are licensed health insurance adjusters and trained in the regulatory, financial and clinical nuances of claims bring far more credibility to the table than automated systems or call center models. Their professional credentials allow them to interpret contracts, assess coding validity and present defensible offers that providers respect.

Prospective negotiation can secure fair pricing before treatment occurs, while post-service negotiation remains essential for bringing inflated charges down to market-based levels. The result is faster resolution, lower costs and fewer disputes reaching arbitration.

2. Comprehensive claim review and auditing 

Many high-cost claims are paid with minimal oversight. A line-item audit or diagnosis-related group validation can reveal inaccurate coding, duplicate charges, misapplied modifiers or inflated drug and supply costs that often go unnoticed.

Plans that engage certified coders and pharmacists — professionals trained to analyze both clinical and financial accuracy — achieve more defensible outcomes. Their findings not only drive savings but also strengthen the documentation needed for stop-loss reimbursement.

By auditing claims prepayment and post-payment, employers can avoid paying inappropriate charges altogether and demonstrate to carriers that their claims are managed with due diligence and accountability.

3. Independent clinical validation 

Medical necessity continues to face scrutiny from regulators and stop-loss underwriters alike. When large or complex claims arise, independent clinical reviews provide the unbiased verification that care was necessary, appropriate and consistent with plan terms.

Conducted by board-certified specialists, these reviews help establish whether treatments are not appropriate, experimental, investigational or misclassified. They also serve as defensible documentation in the event of a stop-loss audit or appeal.

Plans that integrate this level of review early in the claim life cycle not only ensure compliance but also safeguard their financial stability.

Why this matters to stop-loss carriers and brokers

Combining stop-loss with disciplined claim management enables brokers to move beyond policy placement into true risk advisory.

Plans that demonstrate expert-led oversight — where licensed adjusters, certified coders and clinical reviewers are involved throughout the claim life cycle — are seen by carriers as lower risk, better documented and easier to underwrite.

That credibility pays off. These plans often earn more favorable renewals, fewer lasered members and greater flexibility in contract structure. For brokers, guiding clients toward this level of rigor strengthens trust with both carriers and employers — proving their value extends well beyond renewal season.

Takeaways for brokers

In today’s high-cost landscape, brokers have an opportunity to move beyond coverage selection and into true risk advisory. That means engaging clients in strategic conversations about how claims are being managed, not simply about how they’re being insured.

Brokers should ask tougher questions about the client’s claims oversight process, explore partnerships with vendors that specialize in negotiation and clinical review, and help clients track performance metrics that reflect measurable savings. 

Just as importantly, brokers should help employers see that cost containment isn’t a one-time effort. It requires ongoing attention to patterns, payment integrity and operational accountability.

Stop-loss coverage remains essential in today’s market, but it’s not a stand-alone solution. As catastrophic claims become more frequent and more costly, combining stop-loss with smarter negotiation, thorough claim review and clinical validation is the key to long-term financial sustainability. Brokers who lead with this mindset help their clients build stronger, more defensible health plans and prove their value well beyond renewal season. 

Bruce D. Roffé, P.D., M.S., H.I.A., is the president and CEO of H.H.C. Group. Contact him at [email protected].